Dr. Ince is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
506 6th St
Room Cp2006
Brooklyn, NY 11215Phone+1 718-780-3664Fax+1 718-780-3673
Summary
- Dr. Tan Ince is a pathologist in Brooklyn, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian Brooklyn Methodist Hospital. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 29 years. He specializes in anatomic pathology and clinical pathology and is experienced in breast cancer and ovarian neoplasms.
Education & Training
- MIT Whitehead InsPost-Doctoral Fellowship, 2001 - 2007
- Brigham and Womens HospitalFellowship, Selective Pathology, 2000 - 2001
- Brigham and Womens HospitalFellowship, Women's and Perinatal Pathology, 2000 - 2001
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2000
- Hacettepe University FOMClass of 1988
Certifications & Licensure
- FL State Medical License 2010 - 2026
- NY State Medical License 2019 - 2026
- MA State Medical License 2001 - 2011
- IN State Medical License 2001 - 2003
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- HPV-YAP1 oncogenic alliance drives malignant transformation of fallopian tube epithelial cells.Chunbo He, Xiangmin Lv, Jiyuan Liu, Jinpeng Ruan, Peichao Chen
EMBO Reports. 2024-10-01 - A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer.Mohamed Omar, J Chuck Harrell, Rulla Tamimi, Luigi Marchionni, Cihat Erdogan
Breast Cancer Research. 2024-09-13 - C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer.Seyedeh Fatemeh Razavipour, Hyunho Yoon, Kibeom Jang, Minsoon Kim, Hend M Nawara
Nature Communications. 2024-06-17
Other
- INVENTIONS (Licensed)Tan A. Ince
https://www.usbio.net/search/media/?q=ince - PATENTSTan A. Ince
https://patents.google.com/?inventor=Tan+Ince
Authored Content
- NIH GrantsOctober 2024
- Google ScholarOctober 2023
- My BibliographyOctober 2023
Press Mentions
- Cell-Based Approach Leads to Novel Discovery in Breast Cancer TreatmentJanuary 5th, 2023
- Transcription Factor Discovery Yields Insights on Breast Cancer OutcomesOctober 14th, 2022
- Tan A. Ince, MD, PhD – Fighting Cancer by Keeping Cancer Cells AliveFebruary 12th, 2017
- Join now to see all
Grant Support
- Culture of tumor versus normal cellsNIH2024–2028
- Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human CancersNational Cancer Institute2018–2024
- Epigenomic Mapping in Human Tumor Stem CellsNational Cancer Institute2010–2015
- Epigenetic Regulation of Normal and Transformed Breast Epithelial Cell PhenotypeDOD_CDMRP2008–2012
- Comparative phenotypic, functional, and molecular analysis of ESC & IPSCNIH2009–2011
- Epigenomic Mapping In Human Tumor Stem CellsNational Cancer Institute2009–2011
- Comparative Phenotypic, Functional, And Molecular Analysis Of ESC And IPSCNational Heart, Lung, And Blood Institute2009–2010
- Development Of Tumor Specific Transcript PanelsNational Cancer Institute2001–2006
Committees
- Pathology Committee, Vice-chair, NRG Oncology 2021 - Present
External Links
- Linkedinhttps://www.linkedin.com/in/tan-ince-8892a6120/
- Weill Cornellhttps://vivo.weill.cornell.edu/display/cwid-tai9015
- Brooklyn Methodist Hospitalhttps://news.weill.cornell.edu/news/2020/01/dr-tan-a-ince-named-chief-of-pathology-at-newyork-presbyterian-brooklyn-methodist
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: